In conclusion, this study reaffirms the relationship between EZH2 and glioma progression, revealing EZH2's role in regulating SLC12A5 expression by methylating its promoter region, thereby impacting glioma progression. The gene discussed is EZH2; the disease is central nervous system cancer.